Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Prevention of Staphylococcus Aureus Endophthalmitis by Topical Gatifloxacin in a Rabbit Prohylaxis Model

L.E. Fernandez; H.P. Sandoval; D.T. Vroman; K.D. Solomon

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3559. doi:

ARVO Annual Meeting Abstract May 2005

Comparison of 5 Fluoroquinolones in Corneal Wound Healing Rate in An Animal Model

L.E. Fernandez de Castro; H.P. Sandoval; D.T. Vroman; K.D. Solomon

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4875. doi:

ARVO Annual Meeting Abstract May 2005

Comparison of 04% Ketorolac Tromethamine Ophthalmic Solution vs 05% Ketorolac Tromethamine Ophthalmic Solution to Prevent Inflammation After Phacoemulsification and Intraocular Lens Implantation: A Prospective, Randomized, Double–Masked, Clinical Trial

H.P. Sandoval; L.E. Fernandez de Castro; D.T. Vroman; K.D. Solomon

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):796. doi:

ARVO Annual Meeting Abstract May 2004

Corneal Endothelial Cell Loss after Lens Extraction Using the Fluid–based System Compared to Ultrasound Phacoemulsification

L.E. Fernandez de Castro; H.P. Sandoval; D.T. Vroman; K.D. Solomon

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):295. doi:

ARVO Annual Meeting Abstract May 2004

Gatifloxacin 0.3% compared to Ciprofloxacin 0.3% to prevent Mycobacterial Keratitis in an animal model

H.P. Sandoval; L.E. Fernandez de Castro; O. Al Sarraf; L.L. Steed; S.J. Brown; D.T. Vroman; K.D. Solomon

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4905. doi:

Advertisement